We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

News · November 22, 2021

AHA: Risk-Benefit of Mitral Valve Surgery Plus Tricuspid Annuloplasty Studied

For mitral valve surgery plus TA, risk for primary end-point event lower at two years, but risk for permanent pacemaker implantation higher



Further Reading